Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Simonides, W. S.
Right arrow Articles by van Hardeveld, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Simonides, W. S.
Right arrow Articles by van Hardeveld, C.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Volume 271, Number 50, Issue of December 13, 1996 pp. 32048-32056
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.

Characterization of the Promoter of the Rat Sarcoplasmic Endoplasmic Reticulum Ca2+-ATPase 1 Gene and Analysis of Thyroid Hormone Responsiveness*

(Received for publication, February 21, 1996, and in revised form, July 30, 1996)

Warner S. Simonides par ", Gregory A. Brent ''', Marc H. M. Thelen par , C. Gerard van der Linden par , P. Reed Larsen and Cornelis van Hardeveld par

From the  Thyroid Division, Brigham and Women's Hospital, Department of Medicine, Harvard Medical School, Boston, Massachusetts 02115 and the par  Laboratory for Physiology, Cardiovascular Research Institute, Vrije Universiteit, Amsterdam 1001 BT, The Netherlands

ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
FOOTNOTES
Acknowledgments
REFERENCES


ABSTRACT

Relaxation of skeletal muscle requires the re-uptake of Ca2+, which is mediated by the sarcoplasmic reticulum Ca2+-ATPase (SERCA). Thyroid hormone (T3) stimulates the expression of the SERCA1 isoform, which is essential for fast skeletal muscle fiber phenotype. We have cloned and studied the first 962 base pairs of the 5'-flanking region of the rat SERCA1 gene. This sequence was tested for T3-regulated expression in transient transfection experiments using COS7 cells and for binding of thyroid hormone receptor (TR) alpha  in mobility shift assays. A construct of the 5'-flanking region and a reporter gene was unresponsive to T3 in the absence of co-transfected thyroid hormone receptor. In the presence of TRalpha , a T3 induction ratio of almost 4.0 was found, and this induction ratio was doubled with co-transfection of an RXR expression plasmid. Analysis of progressive 5'-deletion fragments of the sequence indicated multiple regions involved in T3 responsiveness. Three regions, R1, R2, and R3, were identified that bound TR complexes in mobility shift assays and conferred T3 responsiveness to a heterologous promoter. The most potent of these thyroid hormone response elements, R3, increased the 2-fold background T3 stimulation of the thymidine kinase promoter to nearly 6-fold. Detailed analysis of this element showed that four TR-binding half-sites, comprising two independent thyroid hormone response elements, interact cooperatively to give the maximal T3 response. T3 regulation of SERCA1 expression is mediated by a complex thyroid hormone response element that may serve to provide a greater range of response in interaction with nuclear receptor partners or cell-specific transcription factors.


INTRODUCTION

Depolarization of skeletal muscle triggers the release of Ca2+ from the sarcoplasmic reticulum (SR),1 activating the contractile machinery. Relaxation requires the re-uptake of Ca2+, and this is mediated by the SR Ca2+-ATPase (EC 3.1.6.38). Three different genes (SERCA1, -2, and -3) encode multiple isoforms of this Ca2+ pump (1, 2, 3, 4) of which SERCA1 and SERCA2a are the predominant isoforms found in skeletal muscle (5, 6, 7, 8, 9, 10). SERCA1 is expressed at a level up to 8-fold higher than SERCA2a (8, 11, 12, 13, 14) and is consequently part of the fast phenotype of skeletal muscle fibers, characterized by high rates of relaxation and contraction. In contrast, SERCA2a is the predominant isoform found in slow skeletal muscle fibers (7, 9, 10).

It is now well established that thyroid hormone (T3) plays an important role in the development and maintenance of the fast phenotype. During neonatal development of fast muscle, T3 stimulates a massive increase in SERCA1 expression (15), as well as the expression of fast isoforms of a number of contractile proteins (16, 17, 18, 19). Furthermore, in adult slow skeletal muscle sufficient levels of T3 can induce a shift from a slow to a fast phenotype (7, 20, 21, 22, 23). For example in rat soleus muscle, T3 stimulation (hypo- to hyperthyroidism (13, 14, 24, 25, 26, 27)) produces a 7-fold increase in total SR Ca2+-ATPase, almost all due to induction or stimulation of expression of SERCA1 in all fibers of this muscle (5, 7). Therefore, the SERCA1 isoform is the primary target for T3 in the development of fast relaxation properties in skeletal muscle. Subsequent work indicated that T3 acts at a pretranslational level, both in neonatal development and in adult muscle (5, 28), and a direct action of T3 was indicated by studies using the skeletal muscle cell line L6 (29, 30). Finally, run-on analysis established that T3 enhances the rate of transcription of the SERCA1 gene (31).

Stimulation of transcription by T3 is mediated by nuclear T3 receptors (TR) (32, 33, 34, 35) that recognize and bind specific DNA sequences called thyroid hormone response elements (TRE) (36, 37, 38). TREs act as enhancers and will confer T3 responsiveness when inserted in a heterologous promoter. Unlike the target sequences of other trans-acting factors, naturally occurring TREs are remarkably variable in structure. Analysis of the TREs in several promoters has yielded the consensus hexamer element (A/G)GGT(C/G)A as the optimal binding site for TR, although specific flanking nucleotides further increase affinity (38, 39, 40, 41, 42, 43). Naturally occurring TREs typically consist of multiple elements (half-sites) arranged as either a direct repeat spaced by 4 base pairs (DR + 4), as an inverted repeat spaced by 0 (palindrome), 1, or 2 base pairs (IR + 1/+ 2), as an inverted palindrome with a 6- or 7-base pair gap (IP + 6/+ 7), or as a combination of these in TREs composed of three or four elements (38, 44, 45, 46, 47, 48, 49). Furthermore, a promoter may contain several TREs contributing to the overall T3 responsiveness (50, 51, 52). The multiple half-site arrangement within a TRE allows for cooperative receptor binding and dimerization or multimerization, which positively correlates with transactivation (44, 53, 54). Deviations from the optimal hexamer sequence and, to a lesser extent, from the optimal spacing between them are common in naturally occurring TREs and are responsible for large differences in TR binding affinity and transactivation potency (44). Depending on the structure of a TRE, TR binding and transactivation can be increased by heterodimerization with a class of apparently ubiquitous nuclear proteins of which the retinoid X receptor (RXR) is a major representative. RXR augments TR binding to most TREs and potentiates T3 induction with no requirement for its natural ligand (9-cis-retinoic acid) (55, 56, 57, 58, 59, 60). Finally, interactions of other transcription factors with single TRs bound to single half-sites have been described, further increasing the potential of T3 to modulate gene transcription (55, 61).

We present an analysis of the first 962 base pairs of the 5'-upstream region of the rat SERCA1 gene, which constitutes a functional, T3-inducible promoter. The T3 responsiveness appears to be mediated by two weak and one strong TRE. A detailed analysis of the strong TRE indicates an unusual array of half-sites, four of which are required for optimal transactivation. This complex arrangement has important implications for T3 gene regulation.


MATERIALS AND METHODS

Isolation and Characterization of the 5'-Flanking Region of the SERCA1 Gene

Unless otherwise indicated all molecular and biological assays were carried out using standard methods (62). A rat (Sprague-Dawley, adult) genomic library in lambda EMBL-3 (Clontech), consisting of 2.3 × 106 independent clones, was screened with the ApaI/KpnI fragment from rabbit SERCA1 cDNA (nt -21 to +635) (gift from Dr. Jonathan Lytton, Brigham and Women's Hospital, Boston, MA). The fragment was labeled by random priming in the presence of [alpha -32P]dATP, and a screening of approximately 1 × 106 clones yielded two independent clones with inserts of 14 and 15 kb. Secondary screening of the clones using alpha -32P-end-labeled synthetic oligonucleotides corresponding to the 5'-nontranslated sequences of the cDNAs of rat SERCA2a (5'-GAGTGCAGGCGGAGGCGAGGAGGC-3') (63) and the non-muscle Ca2+ pump isoform SERCA3 (5'-TCAAGTTCGCAGCATTCTGCACAGT-3') (1) proved negative. The clones were characterized by Southern analysis of restriction fragments using various rat SERCA1 cDNA fragments as probes and an oligonucleotide complementary to the 5'-nontranslated sequence of the SERCA1 cDNA (5'-GGGGGTGATGTATTCCTTCTTA-3'). A 3.2-kb SacI-SacI fragment that hybridized to both a 5'-cDNA fragment (-65 to +118 (SacI), +1 is the translation initiation site) and the oligonucleotide was cloned into pTZ19U (pTZ19U/Sac3.2) and analyzed by restriction enzyme digestions. A 3' SphI-SacI fragment of 1.5 kb was subcloned and sequenced on both strands by the dideoxy chain termination method using synthetic oligonucleotides as primers.

Determination of the Transcription Initiation Site

A synthetic oligonucleotide (5'GGGGGTGATGTATTCCTTCTTA-3') derived from the 5'-noncoding sequence of the rat SERCA1 cDNA, 44 nt upstream of the translation initiation site, was used in the primer extension assay. The primer was end-labeled with [gamma -32P]dATP and T4 kinase (Pharmacia Biotech Inc.) and hybridized at 55 °C overnight to approximately 15 µg of total RNA, isolated from gastrocnemius muscle of 6-week-old rats by the guanidinium thiocyanate method (64). In this muscle, SERCA1 is expressed at a high level and its message comprises over 95% of total SR Ca2+-ATPase mRNA (5). Primer extension using reversed transcriptase (Life Technologies, Inc.) was performed for 1 h at 37 °C in the presence of actinomycin D and analyzed on a 5% denaturing polyacrylamide sequencing gel.

The probe used in the mung bean nuclease method was synthesized from a single-stranded M13 DNA template containing an approximately 900-nt RNA-like PstI (-335 nt from the ATG start site) -SacI fragment subcloned from the SERCA1 genomic clone pTZ19U/Sac3.2 (see above). The above-described synthetic oligonucleotide was used as a primer in the synthesis of the complementary DNA strand in the presence of [alpha -32P]dATP. After digestion with PstI, the single-stranded primer PstI fragment was separated on a 5% denaturing polyacrylamide gel. The position of the fragment was determined by autoradiography, and the fragment was cut from the gel and electro-eluted. Of this fragment, 2-4 × 105 cpm was used as a probe and hybridized overnight with approximately 15 µg of total RNA at 40 °C in 70% formamide. The nuclease reaction was performed using 30, 100, and 300 units of mung bean nuclease (Promega) for 2 h at 37 °C, and fragments were analyzed on a 5% denaturing polyacrylamide sequencing gel.

Plasmid Construction and Transient Transfection

Seven fragments with consecutive 5'-ends at -962, -584, -490, -327, -269, -220, and -141 and a common 3'-end at +91 (+1 is the transcription initiation site) were obtained from pTZ19U/Sac3.2 using available restriction sites in combination with polymerase chain reaction using synthetic oligonucleotide primers with attached restriction sites. These were cloned upstream of the chloramphenicol acetyltransferase (CAT) gene in the polylinker site of the promoterless expression vector pOCAT2 (65). The constructs were sequenced to check the fidelity of the polymerase chain reactions. Synthetic double-stranded oligonucleotides with either BamHI or XbaI ends and comprising wild type or mutated TRE sequences were inserted in the appropriate restriction site upstream of the thymidine kinase promoter in the CAT expression vector pUTKAT3 (65). Transfections of COS7 cells using the calcium-phosphate precipitation method were carried out as described previously (66). Transfections were done in pairs, and a mix for two plates (6 cm diameter) included 20 µg of CAT expression plasmid and 6 µg of pTKGH or pCMV-beta Gal. The latter two plasmids constitutively express human growth hormone and beta -galactosidase, respectively, and were used to correct for differences in transfection efficiency between plates. Where appropriate, expression plasmids (CDM8) for mouse TRalpha 1 and human RXRalpha (gift of Drs. D. Mangelsdorf and R. Evans, Salk Institute, La Jolla, CA) or mouse RXRbeta (gift from Dr. Keiko Ozato, NIH, Bethesda, MD) were present at 1 µg. Cell culture medium with or without 50 nM T3 was made with charcoal-stripped serum. CAT activities (overnight incubations) were determined with the phase extraction method (67) and expressed relative to the level of human growth hormone or beta -galactosidase activity. The presented T3 induction ratio's are the mean CAT/human growth hormone (or beta Gal) levels of T3-treated to untreated plates, performed in duplicate, of at least four independent transfections. Statistical significance of differences between groups was calculated using Student's two-sided t test.

Mobility Shift DNA Assay

Gel shift experiments were carried out with purified chicken TRalpha (cTRalpha ). The isolation of receptor following overexpression in Escherichia coli BL21 DE3 pLYSs and conditions for gel shift experiments have been described before (53). The double-stranded oligonucleotides comprising TREs, or fragments thereof, used in the construction of pUTKAT3 plasmids were labeled by Klenow fill-in reaction using [32P]dTTP and gel-purified. Labeled probe (15-25,000 cpm, 4.5-7.5 fmol) was incubated with cTRalpha (15-200 fmol) in 30 µl containing 100 ng of poly(dI-dC), 88 mM KCl, 10% glycerol, 25 mM Tris-HCl, 500 µM EDTA, 0.05% Triton X-100, 10 mM beta -mercaptoethanol, 20 nM T3, and 5 µg of bovine serum albumin. The binding reactions were incubated for 30 min at room temperature and analyzed at 4 °C on a 5% nondenaturing polyacrylamide gel in low ionic strength buffer (10 mM Tris-HCl, 7.5 mM glacial acetic acid, and 40 mM EDTA, pH 7.8) and electrophoresed at 500 V in the same buffer with constant circulation. Gels were dried under vacuum and autoradiographed for 5-15 h. Receptor binding was quantified by laser densitometry (Pharmacia) of autoradiographs exposed for various periods. The assignment of monomer and dimer bands for a given TRE (fragment) was done by comparison with the characterized patterns of shifts of rGH or lysozyme silencer TREs run on the same gel. The fraction of TRE bound by TR monomer, dimer, or oligomer was calculated by dividing the density of a given band by that of the sum of all retarded bands and free probe. The data shown are representative of at least two independent experiments.


RESULTS

Isolation and Characterization of the 5'-Flanking Region of the SERCA1 Gene

A rat genomic DNA library in lambda EMBL3 was screened with a rabbit SERCA1 cDNA fragment, as described under "Materials and Methods," and two independent clones (lambda 8 and lambda 17) with 14- and 15-kb SERCA1 inserts were isolated. These inserts overlapped significantly, with the most 5'-situated insert (lambda 8) containing greater than 6 kb of sequence upstream of the transcription initiation site (Fig. 1A). A 1.5-kb SphI-SacI fragment was subcloned and sequenced. Comparison with rat cDNA and rabbit SERCA1 genomic sequences (68) revealed that this fragment contained part of the first intron, the first exon, and 962 base pairs of sequence upstream of the transcription initiation site.


Fig. 1. Characterization of the 5'-flanking sequence of the rat SERCA1 gene. A, isolation of lambda 8 is described under "Materials and Methods." The approximate position of restriction endonuclease sites in the 14-kb genomic insert is indicated. The bottom part of panel A gives the SphI-SacI fragment that was subcloned into pTZ19U. The restriction sites used in further subcloning for sequencing purposes are indicated, and horizontal arrows show the partially overlapping stretches that were sequenced, also using synthetic oligonucleotides as primers. The transcription initiation site (+1) was determined as described in the text (see also Fig. 2), and nucleotides are numbered relative to this. Sequence comparison identified exon 1 (filled bar) and intron 1 (hatched bar) with boundary at nt +183. Panel B presents the SERCA1 5'-flanking region, sequenced on both strands, from nt -962 to nt +106. The transcription start site is marked by an open arrow, and canonical promoter sequences (TATA and CCAAT) are circled. The 5'-ends of the fragments used in this study are indicated by arrowheads at nt -584, -490, -327, -269, -220, and -141. A possible NF-1 site (TGG(N)7CCA) is underlined, sequences corresponding to the E-box motif (CANNTG) are boxed, and those corresponding to the consensus TR-binding hexamer ((A/G)GGT(C/G)A) are marked by horizontal arrows.
[View Larger Version of this Image (41K GIF file)]


The rat SERCA1 5'-genomic sequence from -962 to +106 (sequenced on both strands) is shown (Fig. 1B). The transcription initiation site, or cap site of the mRNA, was mapped to a thymidine at -184, rather than to the guanidine two positions downstream as reported for the rabbit (68). Mapping was performed by primer extension analysis using a primer derived from the 5'-noncoding sequence, as well as by mung bean nuclease mapping using the same primer (see "Materials and Methods"). The product of a sequence analysis of the genomic fragment, using the 5'-noncoding primer, was run alongside the product of both the primer extension and the nuclease mapping in an electrophoretic gel. This allowed unequivocal identification of the T-residue at -184 as the 5'-end (Fig. 2), and adds 18 bases to the previously published 5'-untranslated region of the rat SERCA1 message (6). The first 200 base pairs of the rat SERCA1 5'-flanking region were 90% identical to the same region in the rabbit gene (68). A TATA-like sequence (CATAA) was found at position -28 and a CCAAT box at position -78. Further sequence inspection revealed a possible NF-1 binding site (TGG(N)7CCA) at position -192, several E-boxes (CANNTG), which bind myogenic factors like MyoD and myogenin (reviewed in Ref. 69), and five TR-binding hexamers corresponding to the consensus sequence (A/G)GGT(C/G)A (Fig. 1B).


Fig. 2. Mapping of the 5'-end of rat SERCA1 mRNA. Left panel, mung bean nuclease mapping. Lane 1, free probe control; lane 2, labeled (single-stranded) probe not hybridized with RNA, and subjected to mung bean nuclease treatment as described under "Material and Methods" (nuclease control). Lanes 3-5, probe hybridized with RNA and treated with decreasing nuclease concentrations; lane 3, 300 units; lane 4, 100 units; lane 5, 30 units. Right panel, primer extension analysis. Lane 1, primer extension analysis using total RNA and a 32P-labeled synthetic oligonucleotide as described under "Material and Methods." GATC lanes, in both panels, dideoxy sequencing lanes of pTZ19U/Sac3.2 with the described oligonucleotide (see "Material and Methods") electrophoresed alongside the nuclease and primer extension analyses on the same gel. The arrowhead indicates the free probe signal; the arrow indicates the location of the major primer extension and nuclease products.
[View Larger Version of this Image (82K GIF file)]


Analysis of T3 Responsiveness of the SERCA1 Promoter

A series of fragments with progressive 5'-deletions and a common 3'-end (at position +91), comprising between 962 and 141 base pairs of 5'-sequence (see Fig. 1B), were cloned upstream of the chloramphenicol acetyltransferase (CAT) gene in the promoterless expression vector pOCAT2, placing the CAT gene under control of the SERCA1 promoter fragment. COS cells were used in the subsequent transient transfection assays, since these cells constitute a well characterized and sensitive system for the analysis of T3 responsiveness. Transfection assays indicated that the minimal construct (-141), containing the CCAAT and TATA box, constitutes a functional promoter as it directed 4-fold higher CAT expression as compared with the pOCAT2 control plasmid. Constructs including additional 5'-sequence displayed similar or somewhat lower activities. None of the constructs showed T3 responsiveness in the functionally TR-deficient COS cells. Co-transfection of a mouse TRalpha expression plasmid, however, induced T3 responsiveness while reducing basal CAT expression. We observed an average 65% reduction of basal CAT activity in all constructs with co-transfection of TR, except for the shortest (-141), where there was 37% inhibition (pOCAT2 basal activity was not affected by TR co-transfection). Basal activity of T3 responsive promoters has previously been shown to be repressed by binding of unliganded TR (70, 71). CAT expression driven by the full-length promoter construct (-962) was stimulated almost 4-fold by 50 nM T3 and deletion to -584 did not significantly reduce T3 induction. However, T3 responsiveness was reduced in three discrete steps upon deletion of sequences between -584 and -490, between -269 and -220, and between -220 and -141 (Fig. 3). The low residual T3 induction of the -141 construct of 1.27 was not significantly different from the pOCAT control.


Fig. 3. T3 responsiveness of SERCA1 promoter fragments. Fragments of the SERCA1 5'-flanking sequence with various 5'-ends and a common 3'-end at +91 were inserted in the promoterless pOCAT2 vector and analyzed for T3 induction in transient transfection assays (see "Materials and Methods"). The mean T3 induction ratios (±S.E.) of at least six independent transfections per construct are shown. Fragment 0 is pOCAT2 without insert. *, significantly different from next shorter fragment (p < 0.05).
[View Larger Version of this Image (15K GIF file)]


Analysis of Putative TREs: Receptor Binding

We inspected the sequences in the fragments of the 5'-flanking region that conferred T3 induction (Fig. 3). All three fragments contained regions that closely matched known TR-binding sequences with spacing configurations found in functional TREs. These three regions (R1, R2, and R3) are depicted in Fig. 4, and some putative half-site hexamers forming DR, IR, or IP structures are indicated by arrows. We tested TRalpha binding to the three regions in gel-shift assays. The specificity of binding was confirmed by competition for bands with excess unlabeled oligo but not with nonspecific DNA (beta -actin). Fig. 5A shows specific receptor binding for each region, with prominent TR homodimer bands on the R1 and R2 elements. R2 also shows multiple higher order oligomers, and these structures are the predominant species in R3. For both R2 and R3, double-stranded probe is shifted at this receptor concentration, yet a significant amount of R1 probe is not, suggesting a lower receptor affinity for this sequence.


Fig. 4. Putative SERCA1 TRE sequences and transactivating activities. The sequences of three regions of the SERCA1 promoter are shown which comprise possible TREs. Putative TR-binding half-sites (hexamers) are underlined, and their orientations are indicated by arrows. The sequences were inserted upstream of the heterologous TK promoter in pUTKAT3 and analyzed for T3 induction in transient transfection assays (see "Materials and Methods"). The mean T3 induction ratios (±S.E.) of at least six independent transfections of pUTKAT3 (control) and the constructs are shown. *, significantly different from pUTKAT3. **, significantly different from Region 1 and Region 2 (p < 0.05).
[View Larger Version of this Image (13K GIF file)]



Fig. 5. Binding of TRalpha to putative TRE's R1, R2, and R3. A, double-stranded elements R1, R2, and R3 (see Fig. 4) were 32P-labeled and incubated with 50 fmol of E. coli-expressed cTRalpha either without competitor, with 400-fold molar excess of cold element, or beta -actin DNA, and the products were analyzed on a nondenaturing polyacrylamide gel (see "Materials and Methods"). Bands corresponding to free probe, TR monomer, dimer, and oligomers are indicated. B, to assess the relative affinity of the three elements, R3 was incubated as above but with increasing amounts of cold competitor DNA, i.e. a 10-, 40-, 120-, or 400-fold molar excess of R3 itself, R2, or R1.
[View Larger Version of this Image (73K GIF file)]


To obtain a better estimate of the relative affinity for TRalpha of the three regions, labeled R3 probe was incubated with TRalpha in the presence of increasing amounts of unlabeled competitor probe, either R3, R2, or R1. The results depicted in Fig. 5B suggest that R2 is a stronger competitor than R3, whereas R1 is less potent (note the disappearance of the dimer band). The order of receptor affinity of the three regions is therefore R2 > R3 > R1.

Analysis of Putative TREs: Transactivation

We then tested whether the R1, R2, and R3 elements conferred T3 responsiveness to a heterologous promoter. Each region was cloned upstream of the viral thymidine kinase promoter driving the CAT gene in pUTKAT3. Fig. 4 summarizes the T3 induction ratios of these constructs. The pUTKAT3 control displayed a 2-fold background induction in agreement with previous observations (44, 66). Insertion of the R1 or the R2 elements resulted in a significant, yet small increase in T3 responsiveness to 3-fold. In contrast, R3 conferred an almost 6-fold T3 induction ratio. The order of potency of transactivation of the three regions is therefore R3 >>  R2 = R1.

Identification of Essential Half-sites in R3

The most potent of the three TREs, R3, was analyzed in more detail. To identify the half-sites that are essential for maximal activity of R3, we first tested the receptor-binding characteristics and transactivating properties of R3 and six partially overlapping fragments of this element. Fig. 6 lists R3 and its fragments which were named according to their half-site composition. It should be noted that the six half-sites A-F were chosen as likely receptor binding sites but that additional hexamer sequences are possible. Analysis of the affinity of TRalpha for R3 showed that at the lowest receptor concentration (15 fmol) approximately 50% of the R3 probe (ABCDEF) was bound and migrated mostly as a dimer complex (Fig. 7, panel A). Some higher order complexes were already visible, and these increased in intensity at higher concentrations of TRalpha where three oligomeric species could be discerned. The relative contribution of the various complexes to the total amount of probe bound is shown in Fig. 7, panel B. Similar analysis of the 5'-half of R3, comprising the putative half-sites ABCD, indicated high affinity dimer binding but no oligomeric species, even at the highest concentration of TRalpha (Fig. 8. panel A). Further truncation of this sequence, leaving BCD, greatly reduced receptor affinity, but dimers were still formed. Analysis of dimer binding to the ABCD and BCD fragments is depicted in panel B of Fig. 8 showing the cooperative nature of binding (sigmoidal curves) and the higher affinity with inclusion of half-site A. These results suggest that the IR + 2 formed by B and D allows for low affinity dimer binding. High affinity receptor binding is supported by the 5'-end of R3, possibly by dimer formation on the IP + 6 formed by A and C. However, alternative dimer complexes, possibly involving the ultimate 5'-hexamer sequence of R3, could not be ruled out. The T3 induction ratio conferred by fragments ABCD and BCD was the same and significantly lower than R3 (Fig. 6). Both truncated R3 sequences can therefore function as a TRE, but the 3'-half of R3 is clearly required for maximal activity.


Fig. 6. Analysis of functional half-sites in Region 3. Sequence of R3 with hexamers assigned A-F. Six fragments of R3 were synthesized and inserted upstream of the heterologous TK promoter in pUTKAT3 and analyzed for T3 induction in transient transfection assays (see "Materials and Methods"). The fragments are indicated in the text according to their half-site composition. The mean T3 induction ratios (±S.E.) of at least six independent transfections per construct are shown. *, significantly different from pUTKAT3 control (2.1 ± 0.1). **, significantly different from fragments (p < 0.05).
[View Larger Version of this Image (20K GIF file)]



Fig. 7. Binding of TRalpha to Region 3. A, 32P-labeled R3 was incubated with 15, 30, 60, or 125 fmol of cTRalpha , and the products were analyzed on a nondenaturing polyacrylamide gel (see "Materials and Methods"). B, plot of the fraction of R3 bound as monomer, dimer, or oligomer and total bound probe as a function of TRalpha input. Band intensities of gels as in panel A, also including shifts with 200 fmol of cTRalpha , were quantified by laser densitometry.
[View Larger Version of this Image (25K GIF file)]



Fig. 8. Binding of TRalpha to fragments of Region 3. Fragments ABCD, BCD, and EF of Region 3 presented in Fig. 6 were 32P-labeled and incubated with 15, 30, 60, or 125 fmol of cTRalpha , and the products were analyzed on a nondenaturing polyacrylamide gel (see "Materials and Methods"). B, plot of the fraction of fragment ABCD, BCD, and EF as well as CDE and DE (see Fig. 10) bound as dimer as a function of TRalpha input. Band intensities of gels were quantified by laser densitometry.
[View Larger Version of this Image (41K GIF file)]


Analysis of receptor binding to the downstream half of R3 (fragment EF) showed low affinity but cooperative dimer formation (Fig. 8, panels A and B). Half-sites E and F are most likely responsible for the observed binding of receptors, and the DR + 2 formed by E and F constitutes a functional TRE conferring a 3.5-fold T3 induction ratio (Fig. 6). R3 therefore consists of an upstream and a downstream TRE contained in fragments ABCD and EF, respectively. Analysis of the transactivating activity of fragment BCDEF (Fig. 6) showed that the sequence 5' of half-site B is essential for maximal transactivating activity. Fragments that partially overlap both domains did not confer T3 responsiveness above background (fragments DE and CDE, Fig. 6).

A mutational analysis was then done to test which of the putative half-sites are required for transactivating activity of the complete R3 element. The core G residues in TR-binding half-sites have been shown to be essential receptor contact points, and mutation of these abolishes binding and functional activity (39, 40, 42, 43, 45, 52). The data in Fig. 9 show that such mutations in either hexamer A (mut-A) or C (mut-C) abolished the function of the upstream domain, i.e. the remaining T3 induction ratio was not different from that conferred by fragment EF (Fig. 6). Construct mut-BD showed that half-sites B and D are not required for activity (Fig. 9). Finally, constructs mut-E and mut-F showed that hexamers E and F are equally essential for activity of the downstream domain, and consequently for maximal activity of R3.


Fig. 9. Functional analysis of putative half-sites in Region 3. Sequence of wild type R3 and mutant elements are presented. Mutated nucleotides are in boldface and underlined. Elements were synthesized and inserted upstream of the heterologous TK promoter in pUTKAT3 and analyzed for T3 induction in transient transfection assays (see "Materials and Methods"). The mean T3 induction ratios (±S.E.) of at least eight independent transfections per construct are shown. The background T3 induction ratio obtained with the pUTKAT3 control (2.0 ± 0.1) was taken as base line in this graph. All values were significantly different from this control. *, significantly different from R3 (p < 0.05).
[View Larger Version of this Image (24K GIF file)]


Concerning the interaction between the functional domains in R3, the data suggest that the downstream domain (EF), because of its considerably lower affinity (Fig. 8), will not contribute to functional activity at limiting receptor concentration. However, we noticed that at the lowest receptor concentration tested, where the upstream domain ABCD should be responsible for all binding, the complete element R3 consistently bound twice as much dimer complex (compare binding data in Fig. 7B and Fig. 8B). This indicates some cooperative interaction between the two domains. We therefore tested receptor binding to fragments DE and CDE, which span the central region and partially overlap each domain. The fragment comprising half-sites DE bound less than 14% of the probe at the highest receptor concentration; however, this was all bound as dimers, suggesting a high degree of cooperativity at a low overall affinity (Fig. 10). Surprisingly, the 5'-extension of this fragment with 3 base pairs, reconstituting half-site C, resulted in a similar cooperative formation of dimers, but with much higher apparent affinity (Fig. 10). The binding data are also depicted in Fig. 8, panel B, showing cooperativity of receptor complex formation, especially in case of fragment CDE.


Fig. 10. Binding of TRalpha to fragments of Region 3. Fragments CDE and DE of Region 3 presented in Fig. 6 were 32P-labeled and incubated with 15, 30, 60, or 125 fmol of cTRalpha , and the products were analyzed on a nondenaturing polyacrylamide gel (see "Materials and Methods"). The fraction of each fragment bound as dimer as a function of TRalpha input is plotted in Fig. 8B.
[View Larger Version of this Image (80K GIF file)]


Potentiation of T3 Response by RXR

Finally, we tested whether the T3 responsiveness of the SERCA1 promoter could be potentiated by RXR. Co-transfection of RXRalpha or -beta did not affect basal promoter activity, either in the presence or absence of TR or T3, and both isoforms augmented T3 induction to the same extent (data not shown). As shown in Fig. 11, co-transfection of an RXR expression plasmid led to an almost doubling of the T3 induction ratio for the two longest constructs, i.e. -575 and -962. Deletion of R3 in construct -490 reduced the RXR potentiation to +50%. Surprisingly, this potentiation of the T3 induction mediated by R1 and R2 was lost upon deletion of sequences immediately upstream of element R2, i.e. between -327 and -269.


Fig. 11. Potentiation of T3-response by RXR. The mean T3 induction ratios (±S.E.) are shown for pOCAT2 and SERCA1 promoter constructs (see Fig. 3) obtained in transient transfections with or without co-transfected RXR expression plasmid. RXRalpha and -beta potentiated the T3 response to the same extent, and results for both were combined for this plot. The presented data are the results of at least six independent transfections. In the case of fragments -322 through -962, the T3 induction ratio in the presence of RXR and TRalpha was significantly higher than in the presence of TRalpha alone (p < 0.05).
[View Larger Version of this Image (39K GIF file)]



DISCUSSION

The Promoter of the SERCA1 Gene of the Rat

Cloning and sequencing of the upstream region of the rat SERCA1 gene indicated that the 5'-nontranslated and initial 200 base pairs of the putative promoter are virtually identical to the rabbit SERCA1 sequence, except that the transcription initiation site is located 2 base pairs upstream to that reported for the rabbit (68). Comparison with the published 559 base pairs of promoter sequence of the SERCA2 gene of the rat (72) reveals no substantial sequence similarity, although three TREs are also thought to be responsible for T3 responsiveness in this gene (51). The marked difference in promoter sequence between SERCA1 and SERCA2 is in line with the different modes of transcriptional regulation of these phenotype-specific isoforms, both in adult and in neonatal skeletal muscle. T3 initially stimulates expression of SERCA1 as well as SERCA2 but then represses SERCA2 in certain muscle fibers (7, 28). Clearly, the availability of two differentially regulated, but otherwise similar, genes allows the skeletal muscle cell to use a broader spectrum of regulatory pathways in governing the important Ca2+ uptake function of the SR.

The SERCA1 promoter contains multiple E-boxes, capable of binding myogenic transcription factors of the MyoD family (69), but no other known cis-elements that confer or enhance muscle-specific expression, such as m-CAT, CArG, GArG, MHox, and MEF-2. Myogenic factors are not essential for function of the SERCA1 promoter used in this study, given its activity in COS cells. However, initial experiments with L6 myoblasts showed a severalfold higher normalized basal expression of the full-length promoter construct as compared with COS cells, suggesting a potential effect of muscle-specific transcription factors. Nevertheless, the observed T3 induction ratio in these experiments was similar to that found in COS cells.2 We chose COS cells to analyze the T3 responsiveness of the promoter in detail, because the low transfection efficiencies and low absolute levels of CAT expression obtained with L6 muscle cells precluded an accurate analysis in these cells.

T3 Induction of the SERCA1 Promoter

The TR-dependent, almost 4-fold (8-fold in the presence of RXR) T3 induction ratio found for the full-length (-962) SERCA1 promoter construct confirms that at least part of the transcriptional activation by T3 is mediated by upstream sequences. The SERCA1 promoter contains several single optimal half-sites for TR binding in the first 327 base pairs. Such binding of receptor to the single perfect half-sites immediately downstream of the CCAAT box (-60) and 22 base pairs downstream of the transcription initiation site (+25) might be expected to interfere with the transcriptional machinery and could be responsible for the TR-dependent, 37% reduction of basal activity of the minimal (-141) promoter, which was not reversed by T3. Although typical TREs consist of two or more half-sites, TR monomers are capable of transactivation (41, 42) also through interaction with other trans-acting factors, such as NF-1, Sp-1, COUP-TF, and CCAAT-binding protein (55, 61). In particular, T3 induction conferred to the thymidine kinase promoter by a single TR-binding half-site was strongly potentiated by an NF-1 site inserted 45 base pairs downstream of this half-site (61). In the SERCA1 promoter, the NF-1 site at -192, which disrupts R1, is located 40 base pairs downstream of a perfect half-site, and another such half-site is located between the NF-1 site and the CCAAT box. Although we assume that regions R1 and R2 are primarily responsible for the T3 response in constructs up to -490, it is possible that additional interactions between TR monomers and other trans-acting factors are involved in this response. Clearly, however, R3 is responsible for the additional T3 responsiveness of the longer constructs.

The identification of regions R1, R2, and R3 as functional TREs was based on specific binding of TR dimers and T3-dependent transactivation of a heterologous promoter. Comparison of the order of affinity with potency of transactivation shows that these parameters are not necessarily correlated, as has been previously noted for other TREs (44, 53, 73). The high affinity binding to R2 is most likely explained by the presence of a perfect hexamer GGGTCA, as well as an almost perfect copy of the extended half-site TGAGGTAACT (central T is a C in R2), shown to be a strong TR binder (39). However, the 9-base pair gap separating these high affinity sites makes a functional interaction less likely (41), although a DR + 12 TRE has recently been identified in the human type 1 deiodinase gene (52). Williams et al. (44) described the transactivating properties of a large number of natural response elements in the context of the TK promoter and comparison with our data would rank R1 and R2 with the bGH, ADH3, and estrogen response elements. All of these are weak T3 responders. R3, on the other hand, ranks with relatively strong elements, predominantly regulated by T3, such as that of the alpha  myosin heavy chain gene and the rGH intronic TRE.

Whether all three TREs contribute to the total T3 response is not known. The 4-fold T3 induction of the promoter more than compensates for the TR-dependent repression of activity and is therefore not the result of hormone-induced dissociation of receptor dimers (74). Presumably, the mechanism of transactivation involves a direct interaction of the receptor complex with the transcription-initiation complex, possibly mediated by adaptor proteins, as has been shown for several members of the steroid hormone receptor superfamily, including TR (75, 76). That such a mechanism may put a limit on the number of these interactions is suggested by previous work in which two copies of the rGH TRE in tandem more than doubled the T3 induction of the TK promoter, but a third copy did not have an additional effect (77). Multiple TREs have been identified in natural promoters (50, 51, 52), and in two cases deletion studies have shown that two TREs contribute to the total T3 responsiveness (50, 52). In view of this we suggest that the T3 response of the full-length SERCA1 promoter construct is the result of R3, possibly in combination with either R1 or R2, rather than of all three regions. This conclusion is supported by a comparison of the rat and rabbit promoter structures (68). The stimulation of SERCA1 expression by T3 is similar in rat and rabbit, but the 5'-sequences of the rabbit and rat SERCA1 gene strongly diverge upstream of position -200. Up to position -450 in the rabbit gene, the overall similarity is less than 60% and, notably, the sequences of R1 and R2 are not conserved. However, between positions -475 and -522, the rabbit sequence contains an almost perfect copy of R3, except for a 3-base pair insertion in the sequence separating the upstream and downstream domains. The essential half-sites A, C, E, and F (see "Discussion") are either fully conserved or mutated to a similar (half-site C) or a more optimal sequence (half-site F):
<UP>    A           C                  E       F</UP>
<UP>C<UNL>CCTCCC</UNL>TAGCGTA<UNL>AGGTTA</UNL>CCA–––TCTGCAC<UNL>TCTCCC</UNL>CT<UNL>TGACCA</UNL> rat</UP>
<UP>CCCTCCCTAGGcTAgGGTTACCATCTTCTGCcCTGTCCCCTTGACCc rabbit</UP>
<UP>S<SC>equence</SC> 1</UP>
The virtually complete conservation of R3, but not of R1 and R2, suggests a significant role for R3 as a regulatory element in the promoter of the SERCA1 gene.

Analysis of R3

The analysis of R3 identified this sequence as an unusual, composite TRE, consisting of an upstream IP domain and a downstream DR domain, both of which can function as independent TREs. This combination resembles the structure of the laminin B1 (LamB1) TRE in which four half-sites are arranged as an upstream IP + 7, touching a DR + 3 (46), although R3 appears to be a stronger TRE, at least when analyzed in COS cells (78). The upstream half of R3, with multiple potential half-sites, can in principle accommodate three likely dimer configurations, i.e. an IR + 2 (B-D), as found in the alpha MHC TRE (47), an IP + 6/7 (A-C), as also found in the lysozyme silencer (Lys-F2) (48) and myelin basic protein TREs (49), and another IP + 6 between B and the ultimate 5'-hexamer of R3. The analysis of receptor binding to R3 fragments (Fig. 8) indicated that the apparent affinity of dimer binding to the B-D domain is approximately 5-fold lower than for the IP + 6/7 domain contained in fragment ABCD. This is in agreement with several studies showing optimal spacing for TR binding for the IP configurations of 6-9 but 0 for the IR (palindrome) (37, 43, 73, 79, 80, 81). The mutational analysis of putative receptor contact sites (Fig. 9) then showed that half-sites B and D are not required for functional activity of the upstream domain but that the core G residues in both A and C are essential. Half-site C, including the two preceding base pairs (TAAGGTTA), is an almost perfect copy of the octamer TAAGGTCA shown to be an optimal TR-binding site (40). It has been shown that the PydPuo nucleotides 5' of the hexamer half-site sequence contribute considerably to affinity and functional potency of a TRE (39, 40, 41, 42, 43, 52), and given the high affinity dimer binding to A and C we suggest that this element is an IP + 7 (43) with an octamer sequence of half-site A of TAGGGAGG.

Further analysis of receptor binding and transactivation by R3 mutants identified hexamers E and F as essential half-sites forming the downstream TRE (DR + 2) in R3. The similar effect of mutating either A, C, E, or F on the potency of R3 (Fig. 9) indicates that functional interaction between both domains depends on dimer formation on each. The affinity of dimer formation for the downstream DR + 2 TRE is much lower than for the A-C element, in agreement with previous studies (43, 82), and it is questionable whether this element by itself would be of relevance. The role of the downstream element appears to depend on its capacity to interact with the upstream element. Such potentiation of dimer binding by a third half-site is well documented for the rGH TRE (53, 54), and this cooperativity is also observed for the four half-sites in the LamB1 TRE, all of which are required for maximal activity (73). The data in Fig. 8 indicate that half-sites C and E may be responsible for the interaction of the upstream and downstream domains. Although the receptor dimer complex formed on E and C (IR + 10) has no transactivating properties (Fig. 6), the relatively high affinity, cooperative binding of receptors to these half-sites could contribute to the formation of functional complexes on both domains in the intact R3. Although dimer binding on an IR + 10 was reported before (83), cooperativity was not observed, and it was much weaker compared with the (optimal) palindrome structure. However, we noticed that the heptamer CATCTGC, separating C and E, is identical to the sequence separating both TR-binding domains in the rat thyrotropin-beta TRE (84). This sequence was shown not to bind TR itself but to be required for optimal TR binding and function of the element. We therefore suggest that the gap sequence between half-site C and E is responsible for the unusual high affinity of this IR + 10, thus affecting the overall TR-binding affinity of R3.

Potentiation by RXR

Heterodimerization of TR with RXR has been shown to increase overall binding affinity for a TRE, but potentiation of T3 induction appears to be dependent on the structure of the TRE (78). Nevertheless, because the RXR's are ubiquitous, they are considered to be the principal partner of TR in vivo. Hsu et al. (78) analyzed several natural TREs in COS cells and showed that only the rat GH and laminin B1 TREs show augmentation of the T3 induction ratio with RXR. They concluded that TREs with more than 2 half-sites support potentiation of transactivation by RXR. Our data, showing a doubling of the T3 induction ratio of the SERCA1 promoter with RXR, are in line with this conclusion, given the complex half-site composition of R3.

We conclude that the T3 responsiveness of the -962-base pair SERCA1 promoter of the rat is primarily mediated by R3. The presence of this TRE in the promoter of the rat SERCA1 gene provides a mechanism for the T3-stimulated expression of this isoform of the SR Ca2+-ATPase in rat skeletal muscle. The complex arrangement of the half-sites in the R3 TRE may be required to mediate the developmental and tissue-specific actions of T3 on SERCA1 gene expression.


FOOTNOTES

*   This work was supported by National Institutes of Health Grant DK 44128. The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EMBL Data Bank with accession number(s) U34282[GenBank].


"   Supported by the Netherlands Organization for Scientific Research (NWO). To whom correspondence should be addressed: Laboratory for Physiology, Cardiovascular Research Institute, Vrije Universiteit, van der Boechorststraat 7, 1081 BT, Amsterdam, The Netherlands. Tel.: 31204448116; Fax: 31204448255; E-mail: ws.simonides.physiol{at}med.vu.nl.
'''   Present address: University of California, 11301 Wilshire Blvd., Los Angeles, CA 90073.
1    The abbreviations used are: SR, sarcoplasmic reticulum; nt, nucleotide(s); SERCA, sarcoplasmic endoplasmic reticulum Ca2+-ATPase; TR, thyroid hormone receptor; TRE, thyroid hormone response elements; CAT, chloramphenicol acetyltransferase; IR, inverted repeat; IP, inverted palindrome; DR, direct repeat; RXR, retinoid X receptor; cTRalpha , chicken TRalpha ; rGH, rat growth hormone; kb, kilobase pair(s).
2    M. H. M. Thelen, W. S. Simonides, and C. van Hardeveld. unpublished observations.

Acknowledgments

We wish to thank Dr. Jonathan Lytton for providing us of with cDNA of rat SERCA1, Drs. Barry Forman and Herbert Samuels for an expression vector for chicken TRalpha , Drs. David Mangelsdorf and Ronald Evans for cDNA of mouse RXRalpha , and Dr. Keiko Ozato for cDNA of mouse RXRbeta .


REFERENCES

  1. Burke, S. E., Lytton, J., MacLennan, D. H., and Shull, G. E. (1989) J. Biol. Chem. 264, 18561-18568 [Abstract/Free Full Text]
  2. MacLennan, D. H., Brandl, C. J., Korczak, B., and Green, N. M. (1985) Nature 316, 696-700 [CrossRef][Medline] [Order article via Infotrieve]
  3. Brandl, C. J., Green, N. M., Korczak, B., and MacLennan, D. H. (1986) Cell 44, 597-607 [CrossRef][Medline] [Order article via Infotrieve]
  4. Brandl, C. J., deLeon, S., Martin, D. R., and MacLennan, D. H. (1987) J. Biol. Chem. 262, 3768-3774 [Abstract/Free Full Text]
  5. Simonides, W. S., van der Linden, G. C., and van Hardeveld, C. (1990) FEBS Lett. 274, 73-76 [CrossRef][Medline] [Order article via Infotrieve]
  6. Wu, K.-D., and Lytton, J. (1993) Am. J. Physiol. 264, C333-C341 [Abstract/Free Full Text]
  7. Muller, A., van der Linden, G. C., Zuidwijk, M. J., Simonides, W. S., Van der Laarse, W. J., and van Hardeveld, C. (1994) Biochem. Biophys. Res. Commun. 203, 1035-1042 [CrossRef][Medline] [Order article via Infotrieve]
  8. Leberer, E., and Pette, D. (1986) Eur. J. Biochem. 156, 489-496 [Medline] [Order article via Infotrieve]
  9. Briggs, F. N., Lee, K. F., Feher, J. J., Wechsler, A. S., Ohlendieck, K., and Campbell, K. (1990) FEBS Lett. 259, 269-272 [CrossRef][Medline] [Order article via Infotrieve]
  10. Jorgensen, A. O., Arnold, W., Pepper, D. R., Kahl, S. D., Mandel, F., and Campbell, K. P. (1988) Cell Motil. Cytoskeleton 9, 164-174 [CrossRef][Medline] [Order article via Infotrieve]
  11. Everts, M. E. (1990) Cell Calcium 11, 343-352 [CrossRef][Medline] [Order article via Infotrieve]
  12. Dulhunty, A. F., Banyard, M. R., and Medveczky, C. J. (1987) J. Membr. Biol. 99, 79-92 [CrossRef][Medline] [Order article via Infotrieve]
  13. Dulhunty, A. F. (1990) Pflügers Arch. 415, 433-439 [CrossRef][Medline] [Order article via Infotrieve]
  14. Everts, M. E., Andersen, J. P., Clausen, T., and Hansen, O. (1989) Biochem. J. 260, 443-448 [Medline] [Order article via Infotrieve]
  15. Simonides, W. S., and van Hardeveld, C. (1989) Endocrinology 124, 1145-1153 [Abstract/Free Full Text]
  16. Gambke, B., Lyons, G. E., Hasselgrove, J., Kelly, A. M., and Rubinstein, N. A. (1983) FEBS Lett. 156, 335-339 [CrossRef][Medline] [Order article via Infotrieve]
  17. Mahdavi, V., Izumo, S., and Nadal-Ginard, B. (1987) Circ. Res. 60, 804-814 [Abstract/Free Full Text]
  18. Butler-Browne, G. S., Herlicoviez, D., and Whalen, R. G. (1984) FEBS Lett. 166, 71-75 [CrossRef][Medline] [Order article via Infotrieve]
  19. d'Albis, A., Chanoine, C., Janmot, C., Mira, J., and Couteaux, R. (1990) Eur. J. Biochem. 193, 155-161 [Medline] [Order article via Infotrieve]
  20. Nicol, C. J., and Bruce, D. S. (1981) Pflügers Arch. 390, 73-79 [CrossRef][Medline] [Order article via Infotrieve]
  21. Nwoye, L., Mommaerts, W. F. H. M., Simpson, D. R., Seraydarian, K., and Marusich, M. (1982) Am. J. Physiol. 242, R401-R408
  22. Müntener, M., van Hardeveld, C., Everts, M. E., and Heizmann, C. W. (1987) Exp. Neurol. 98, 529-541 [CrossRef][Medline] [Order article via Infotrieve]
  23. Fitts, R. H., Winder, W. W., Brooke, M. H., Kaiser, K. K., and Holloszy, J. O. (1980) Am. J. Physiol. 238, C15-C20 [Abstract/Free Full Text]
  24. Kim, D. H., Witzmann, F. A., and Fitts, R. H. (1982) Am. J. Physiol. 243, C151-C155 [Abstract/Free Full Text]
  25. Simonides, W. S., and van Hardeveld, C. (1985) Biochim. Biophys. Acta 844, 129-141 [Medline] [Order article via Infotrieve]
  26. Simonides, W. S., and van Hardeveld, C. (1986) Cell Calcium 7, 147-160 [CrossRef][Medline] [Order article via Infotrieve]
  27. Simonides, W. S., and van Hardeveld, C. (1990) Anal. Biochem. 191, 321-331 [CrossRef][Medline] [Order article via Infotrieve]
  28. van der Linden, G. C., Simonides, W. S., and van Hardeveld, C. (1992) Mol. Cell. Endocrinol. 90, 125-131 [CrossRef][Medline] [Order article via Infotrieve]
  29. Muller, A., van Hardeveld, C., Simonides, W. S., and van Rijn, J. (1991) Biochem. J. 275, 35-40
  30. Muller, A., van Hardeveld, C., Simonides, W. S., and van Rijn, J. (1992) Biochem. J. 283, 713-718
  31. Thelen, M. H. M., Muller, A., Zuidwijk, M. J., van der Linden, G. C., Simonides, W. S., and van Hardeveld, C. (1994) Biochem. J. 303, 467-474
  32. Lazar, M. A. (1993) Endocr. Rev. 14, 184-193 [Abstract/Free Full Text]
  33. Glass, C. K., and Holloway, J. M. (1990) Biochim. Biophys. Acta 1032, 157-176 [Medline] [Order article via Infotrieve]
  34. Yen, P. M., and Chin, W. W. (1994) Trends Endocrinol. Metab. 5, 65-72
  35. Evans, R. M. (1988) Science 240, 889-895 [Abstract/Free Full Text]
  36. Glass, C. K. (1994) Endocr. Rev. 15, 391-407 [Abstract/Free Full Text]
  37. Desvergne, B. (1994) Mol. Cell. Endocrinol. 100, 125-131 [CrossRef][Medline] [Order article via Infotrieve]
  38. Williams, G. R., and Brent, G. A. (1994) in Molecular Endocrinology. Basic Concepts and Clinical Correlations (Weintraub, B., ed), pp. 217-239, Raven Press, New York
  39. Kim, H.-S., Crone, D. E., Sprung, C. N., Tillman, J. B., Force, W. R., Crew, M. D., Mote, P. L., and Spindler, S. R. (1992) Mol. Endocrinol. 6, 1489-1501 [Abstract/Free Full Text]
  40. Katz, R. W., and Koenig, R. J. (1993) J. Biol. Chem. 268, 19392-19397 [Abstract/Free Full Text]
  41. Katz, R. W., Subauste, J. S., and Koenig, R. J. (1995) J. Biol. Chem. 270, 5238-5242 [Abstract/Free Full Text]
  42. Schrader, M., Becker-Andre, M., and Carlberg, C. (1994) J. Biol. Chem. 269, 6444-6449 [Abstract/Free Full Text]
  43. Carlberg, C. (1993) Biochem. Biophys. Res. Commun. 195, 1345-1353 [CrossRef][Medline] [Order article via Infotrieve]
  44. Williams, G. R., Harney, J. W., Moore, D. D., Larsen, P. R., and Brent, G. A. (1992) Mol. Endocrinol. 6, 1527-1537 [Abstract/Free Full Text]
  45. Brent, G. A., Harney, J. W., Chen, Y., Warne, R. L., Moore, D. D., and Larsen, P. R. (1989) Mol. Endocrinol. 3, 1996-2004 [Abstract/Free Full Text]
  46. Vasios, G. W., Gold, J. D., Petkovich, M., Chambon, P., and Gudas, L. J. (1989) Proc. Natl. Acad. Sci. U. S. A. 86, 9099-9103 [Abstract/Free Full Text]
  47. Izumo, S., and Mahdavi, V. (1988) Nature 334, 539-542 [CrossRef][Medline] [Order article via Infotrieve]
  48. Baniahmad, A., Steiner, C., Kohne, A. C., and Renkawitz, R. (1990) Cell 61, 505-514 [CrossRef][Medline] [Order article via Infotrieve]
  49. Farsetti, A., Desvergne, B., Hallenbeck, P., Robbins, J., and Nikodem, V. M. (1992) J. Biol. Chem. 267, 15784-15788 [Abstract/Free Full Text]
  50. Suzuki, S., Miyamoto, T., Opsahl, A., Sakurai, A., and DeGroot, L. (1994) Mol. Endocrinol. 8, 305-314 [Abstract/Free Full Text]
  51. Hartong, R., Wang, N., Kurokawa, R., Lazar, M. A., Glass, C. K., Apriletti, J. W., and Dillmann, W. H. (1994) J. Biol. Chem. 269, 13021-13029 [Abstract/Free Full Text]
  52. Toyoda, N., Zavacki, A. N., Maia, A. L., Harney, J. W., and Larsen, P. R. (1995) Mol. Cell. Biol. 15, 5100-5112 [Abstract]
  53. Brent, G. A., Williams, G. R., Harney, J. W., Forman, B. M., Samuels, H. H., Moore, D. D., and Larsen, P. R. (1992) Mol. Endocrinol. 6, 502-514 [Abstract/Free Full Text]
  54. Williams, G. R., Harney, J. W., Forman, B. M., Samuels, H. H., and Brent, G. A. (1991) J. Biol. Chem. 266, 19636-19644 [Abstract/Free Full Text]
  55. Berrodin, T. J., Marks, M. S., Ozato, K., Linney, E., and Lazar, M. A. (1992) Mol. Endocrinol. 6, 1468-1478 [Abstract/Free Full Text]
  56. Leid, M., Kastner, P., Lyons, R., Nakshatri, N., Saunders, M., Zacharewski, T., Chen, J.-Y., Staub, A., Garnier, J.-M., Mader, S., and Chambon, P. (1992) Cell 68, 377-395 [CrossRef][Medline] [Order article via Infotrieve]
  57. Heyman, R. A., Mangelsdorf, D. J., Dyck, J. A., Stein, R. B., Eichele, G., Evans, R. M., and Thaller, C. (1992) Cell 68, 397-406 [CrossRef][Medline] [Order article via Infotrieve]
  58. Mangelsdorf, D. J., Borgmeyer, U., and Heyman, R. A. (1992) Genes Dev. 6, 329-344 [Abstract/Free Full Text]
  59. Zhang, X.-K., Hoffmann, B., Tran, P. B.-V., Graupner, G., and Pfahl, M. (1992) Nature 355, 441-446 [CrossRef][Medline] [Order article via Infotrieve]
  60. Kliewer, S. A., Umesono, K., Mangelsdorf, D. J., and Evans, R. M. (1992) Nature 355, 446-449 [CrossRef][Medline] [Order article via Infotrieve]
  61. Voz, M. L., Peers, B., Wiedig, M. J., Jacquemin, P., Belayew, A., and Martial, J. A. (1992) Mol. Cell. Biol. 12, 3991-3997 [Abstract/Free Full Text]
  62. Ausubel, F. E., Brent, R., Kingston, R. E., Moore, D. D., Seidman, J. G., and Struhl, K. (eds) (1987) Current Protocols in Molecular Biology, John Wiley & Sons, Inc., New York
  63. Lompre, A.-M., de la Bastie, D., Boheler, K. R., and Schwartz, K. (1989) FEBS Lett. 249, 35-41 [CrossRef][Medline] [Order article via Infotrieve]
  64. Chomczynski, P., and Sacchi, N. (1987) Anal. Biochem. 162, 156-159 [Medline] [Order article via Infotrieve]
  65. Prost, E., and Moore, D. D. (1986) Gene (Amst.) 45, 107-111 [CrossRef][Medline] [Order article via Infotrieve]
  66. Brent, G. A., Larsen, P. R., Harney, J. W., Koenig, R. J., and Moore, D. D. (1989) J. Biol. Chem. 264, 178-182 [Abstract/Free Full Text]
  67. Seed, B., and Sheen, J.-Y. (1988) Gene (Amst.) 67, 271-277 [CrossRef][Medline] [Order article via Infotrieve]
  68. Korczak, B., Zarain-Herzberg, A., Brandl, C. J., Ingles, C. J., Green, N. M., and MacLennan, D. H. (1988) J. Biol. Chem. 263, 4813-4819 [Abstract/Free Full Text]
  69. Olson, E. N. (1993) Mol. Endocrinol. 7, 1369-1378 [Free Full Text]
  70. Brent, G. A., Dunn, M. K., Harney, J. W., Gulick, T., Larsen, P. R., and Moore, D. D. (1989) New Biol. 1, 329-336 [Medline] [Order article via Infotrieve]
  71. Graupner, G., Wills, K. N., Tzukerman, M., Zhang, X.-K., and Pfahl, M. (1989) Nature 340, 653-656 [CrossRef][Medline] [Order article via Infotrieve]
  72. Rohrer, D. K., Hartong, R., and Dillmann, W. H. (1991) J. Biol. Chem. 266, 8638-8646 [Abstract/Free Full Text]
  73. Williams, G. R., Zavacki, A. M., Harney, J. W., and Brent, G. A. (1994) Endocrinology 134, 1888-1896 [Abstract/Free Full Text]
  74. Miyamoto, T., Suzuki, S., and Degroot, L. J. (1993) Mol. Endocrinol. 7, 224-231 [Abstract/Free Full Text]
  75. Ing, N. H., Beekman, J. M., Tsai, S. Y., Tsai, M.-J., and O'Malley, B. W. (1992) J. Biol. Chem. 267, 17617-17623 [Abstract/Free Full Text]
  76. Baniahmad, A., Ha, I., Reinberg, D., Tsai, S., Tsai, M.-J., and O'Malley, B. W. (1993) Proc. Natl. Acad. Sci. U. S. A. 90, 8832-8836 [Abstract/Free Full Text]
  77. Brent, G. A., Williams, G. R., Harney, J. W., Forman, B. M., Samuels, H. H., Moore, D. D., and Larsen, P. R. (1991) Mol. Endocrinol. 5, 542-548 [Abstract/Free Full Text]
  78. Hsu, J., Zavacki, A. M., Harney, J. W., and Brent, G. A. (1995) Endocrinology 136, 421-430 [Abstract]
  79. Kurokawa, R., Yu, V., Naar, A., Kyakumoto, S., Han, Z., Silverman, S., Rosenfeld, M. G., and Glass, C. K. (1993) Genes Dev. 7, 1423-1435 [Abstract/Free Full Text]
  80. Wahlstrom, G. M., Sjoberg, M., Andersson, M., Nordstrom, K., and Vennstrom, B. (1992) Mol. Endocrinol. 6, 1013-1022 [Abstract/Free Full Text]
  81. Glass, C. K., Holloway, J. M., Devary, O. V., and Rosenfeld, M. G. (1988) Cell 54, 313-323 [CrossRef][Medline] [Order article via Infotrieve]
  82. Miyamoto, T., Suzuki, S., and Degroot, L. J. (1994) Mol. Cell. Endocrinol. 102, 111-117 [CrossRef][Medline] [Order article via Infotrieve]
  83. Forman, B. M., Casanova, J., Raaka, B. M., Ghysdael, J., and Samuels, H. H. (1992) Mol. Endocrinol. 6, 429-442 [Abstract/Free Full Text]
  84. Bodener, D. L., Mroczynski, M. A., Weintraub, B. D., Radovick, S., and Wondisford, F. E. (1991) J. Biol. Chem. 266, 21666-21673 [Abstract/Free Full Text]

©1996 by The American Society for Biochemistry and Molecular Biology, Inc.

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
EndocrinologyHome page
J. Ukropec, R. V. P. Anunciado, Y. Ravussin, and L. P. Kozak
Leptin Is Required for Uncoupling Protein-1-Independent Thermogenesis during Cold Stress
Endocrinology, May 1, 2006; 147(5): 2468 - 2480.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
S. Fourcade, S. Savary, C. Gondcaille, J. Berger, A. Netik, F. Cadepond, M. El Etr, B. Molzer, and M. Bugaut
Thyroid Hormone Induction of the Adrenoleukodystrophy-Related Gene (ABCD2)
Mol. Pharmacol., June 1, 2003; 63(6): 1296 - 1303.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. Danzi, K. Ojamaa, and I. Klein
Triiodothyronine-mediated myosin heavy chain gene transcription in the heart
Am J Physiol Heart Circ Physiol, June 1, 2003; 284(6): H2255 - H2262.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
Y.-Y. Liu and G. A. Brent
A Complex Deoxyribonucleic Acid Response Element in the Rat Ca2+/Calmodulin-Dependent Protein Kinase IV Gene 5'-Flanking Region Mediates Thyroid Hormone Induction and Chicken Ovalbumin Upstream Promoter Transcription Factor 1 Repression
Mol. Endocrinol., November 1, 2002; 16(11): 2439 - 2451.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Hadri, A. Ozog, F. Soncin, and A.-M. Lompre
Basal Transcription of the Mouse Sarco(endo)plasmic Reticulum Ca2+-ATPase Type 3 Gene in Endothelial Cells Is Controlled by Ets-1 and Sp1
J. Biol. Chem., September 20, 2002; 277(39): 36471 - 36478.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
D. Sharma and J. D. Fondell
Ordered recruitment of histone acetyltransferases and the TRAP/Mediator complex to thyroid hormone-responsive promoters in vivo
PNAS, June 11, 2002; 99(12): 7934 - 7939.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
P. M. Yen
Physiological and Molecular Basis of Thyroid Hormone Action
Physiol Rev, July 1, 2001; 81(3): 1097 - 1142.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
H. Mitchell-Felton and S. C. Kandarian
Normalization of muscle plasmid uptake by Southern blot: application to SERCA1 promoter analysis
Am J Physiol Cell Physiol, December 1, 1999; 277(6): C1269 - C1276.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
D. G. Peters, H. Mitchell-Felton, and S. C. Kandarian
Unloading induces transcriptional activation of the sarco(endo)plasmic reticulum Ca2+-ATPase 1 gene in muscle
Am J Physiol Cell Physiol, May 1, 1999; 276(5): C1218 - C1225.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Mitchell-Felton, R. B. Hunter, E. J. Stevenson, and S. C. Kandarian
Identification of Weight-bearing-responsive Elements in the Skeletal Muscle Sarco(endo)plasmic Reticulum Ca2+ ATPase (SERCA1) Gene
J. Biol. Chem., July 21, 2000; 275(30): 23005 - 23011.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. de Meis
Uncoupled ATPase Activity and Heat Production by the Sarcoplasmic Reticulum Ca2+-ATPase. REGULATION BY ADP
J. Biol. Chem., June 29, 2001; 276(27): 25078 - 25087.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Simonides, W. S.
Right arrow Articles by van Hardeveld, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Simonides, W. S.
Right arrow Articles by van Hardeveld, C.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1996 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement